Gait Evaluation in Haemophiliac Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
ClinicalTrials.gov Identifier:
NCT00824798
First received: January 16, 2009
Last updated: July 10, 2014
Last verified: July 2014

January 16, 2009
July 10, 2014
January 2009
January 2011   (final data collection date for primary outcome measure)
evaluate specific changes in gait in patients suffering from haemophilic arthropathy [ Time Frame: 01/2009 ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00824798 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Gait Evaluation in Haemophiliac Patients
Gait Evaluation in Haemophiliac Patients

Joint damage secondary to recurrent haemarthroses and chronic synovitis represents the commonest clinical manifestation of haemophilia. Incapacitating pain, loss of joint stability and mobility, axial deviation, deterioration and decreased function are the most frequent complains in patients with severe haemophilic arthropathy In this context, the purpose of our study is to examine and analyse specific changes in gait in patients suffering from haemophilic arthropathy and determine the impact on health-related quality of life in terms of conceptual components of pain and stiffness, psychosocial stress, disability, and activity limitations as recommended by the International Classification of Function (ICF) recently published by the World Health Organization.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample

haemophilia A or B, mild, moderate or severe.

  • Hemophilia A
  • Hemophilia B
Not Provided
haemophiliacs A and B
haemophiliacs A and B mild, moderate or severe from 4 to 80 years old, with or without inhibitors.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
200
January 2012
January 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • haemophilia A or B
  • aged more than 4 years

Exclusion Criteria:

  • impossibility to walk on a treadmill
  • recent joint haemarthrosis or muscle haematoma
Male
4 Years to 80 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Belgium
 
NCT00824798
READ-LOBET-02, READ-LOBET-02
Yes
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Not Provided
Not Provided
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
July 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP